McDermott Will & Schulte, a global law firm

Jeremy also routinely provides complex regulatory counseling and advice on managed care legal issues with a focus on requirements affecting commercial health insurance, the Medicare Advantage and Part D programs and state Medicaid managed care programs. He provides regulatory support to health plan clients on significant regulatory matters and litigation, such as Medicare Advantage risk adjustment compliance and investigations, qui tam actions relating to Medicaid managed care program compliance and class actions relating to health plan coverage policies.

He provides regulatory counseling related to significant managed care transactions, including leading a team as health regulatory counsel to CVS in its $69 billion acquisition of Aetna. Jeremy also regularly represents private equity clients selling, acquiring or investing in managed care companies and other healthcare organizations. He has experience managing the regulatory approval process for managed care transactions, including obtaining insurance department, Medicare Advantage program, and state Medicaid agency regulatory approvals.

Jeremy is a frequent speaker at national healthcare industry conferences and has been quoted in trade and national publications, including HealthPayer Intelligence, Modern Healthcare, Managed Care Executive, Business Insurance and Vox.com.

See Less

• Represented a state’s largest health insurer in drafting and negotiating a global shared-risk agreement with the state’s largest health system
• Developed a template global shared-risk agreement for a large health insurer operating in multiple states
• Assisted a state’s largest insurer in moving its primary care physician compensation entirely away from fee-for-service to a value-based model
• Drafted and negotiated a Part D and commercial pharmacy benefit management (PBM) agreement between a state’s largest insurer and a national PBM

See Less